Results 191 to 200 of about 560,117 (294)

Naloxone dosing in the era of synthetic opioids: Applying the Goldilocks principle. [PDF]

Addiction
Gonzalez Utrilla M, Chesney E, Neale J, Metrebian N, Kalk N, Skulberg AK, Dietze P, Smith M, Strang J.   +8 more
europepmc   +1 more source

Characteristics and Trends of Prehospital Encounters for Opioid Overdoses Among US Youth, 2018-2022.

JAMA
Lim JK, Ramgopal S, Hoffmann JA, Lorenz D, Toce MS.   +4 more
europepmc   +1 more source

Pattern of Buprenorphine Treatment Retention Among Youth Aged 10 to 18 Years-US, 2015 to 2021.

JAMA Pediatr
Connolly S, Terranella A, Guy GP, Mikosz CA.   +3 more
europepmc   +1 more source

Injectable-Only Overlapping Buprenorphine Starting Protocol in a Low-Threshold Setting.

JAMA Netw Open
Waters RC, Hoog J, Bell C, Toland P, Valley J, Hurtado L, Kallsen MA, Johnson T, Gerard A, Fockele CE, Klein JW.   +10 more
europepmc   +1 more source

Demographic Perspectives and De-escalation Challenges in Pediatric Emergency Care for Children with Special Health Care Needs.

J Emerg Trauma Shock
Rivera-Koberstein N, Agrawal A, Galwankar S.   +2 more
europepmc   +1 more source

Trends and Disparities in Initiation of Buprenorphine in US Emergency Departments, 2013-2022.

JAMA Netw Open
Chhabra N, Smith D, Dickinson G, Caglianone L, Taylor RA, D'Onofrio G, Karnik NS.   +6 more
europepmc   +1 more source

Naloxone Use, 911 Calls, and Emergency Visits After Nonfatal Overdose.

JAMA Netw Open
Saloner B, Fredericks PJ, Byrne L, Hurst A, Kerins L, Hulsey EG, Rwan J, Bandara S.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CLINICAL PHARMACOLOGY OF NARCOTIC ANTAGONISTS *

Annals of the New York Academy of Sciences, 1978
Both naloxone and naltrexone are effective narcotic antagonists with minimal agonistic effects and a wide margin of safety. Naloxone is useful in the treatment of narcotic overdose and it is helpful in the quantification of physical dependence. Naltrexone is pharmacologically successful as an orally effective, long-acting antagonist but its clinical ...
C. O'brien, R. Greenstein, J. Ternes, G. Woody   +3 more
semanticscholar   +4 more sources